Nonalcoholic Steatohepatitis Clinical Trials
Nonalcoholic Steatohepatitis clinical trials test new medications, devices, and lifestyle interventions for nonalcoholic Steatohepatitis and related metabolic health. Corterve aggregates actively recruiting Nonalcoholic Steatohepatitis studies from ClinicalTrials.gov so you can browse them by location and eligibility. Many metabolic trials monitor weight, blood sugar, or cardiovascular markers over time. This page provides general information, not medical advice; consult your healthcare provider before joining a study.
Recruiting Nonalcoholic Steatohepatitis studies
- Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in VeteransNCT05526144PHASE2VA Office of Research and DevelopmentColumbia, Missouri
- Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin ResistanceNCT05165706NAStanford UniversityStanford, California
- Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic SteatohepatitisNCT03587831NAUniversity of MinnesotaSan Francisco, California
- A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASHNCT06419374PHASE389bio, Inc.Birmingham, Alabama
- Investigating the Link Between Type 2 Immunity and NAFLD in Human ObesityNCT04232566Mayo ClinicScottsdale, Arizona
- A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASHNCT06528314PHASE3Akero Therapeutics, IncBirmingham, Alabama
- Low-Dose Pioglitazone in Patients With NASH (AIM 2)NCT04501406PHASE2University of FloridaGainesville, Florida
- Non-Invasive Quantification of Liver Health in NASH (N-QUAN)NCT04054310NAPerspectumChandler, Arizona
- Estrogen Administration for the Treatment of NASH in Postmenopausal WomenNCT04833140PHASE3Massachusetts General HospitalBoston, Massachusetts
- A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)NCT06318169PHASE389bio, Inc.Birmingham, Alabama
- Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced FibrosisNCT05720663Virginia Commonwealth UniversityRochester, Minnesota
- Evaluating the Pharmacokinetics and Safety of MiricorilantNCT07553663PHASE1Corcept TherapeuticsSan Antonio, Texas
Nonalcoholic Steatohepatitis trials by state
Nonalcoholic Steatohepatitis trials by metro
Frequently asked questions
- How do I find recruiting Nonalcoholic Steatohepatitis clinical trials?
- Corterve aggregates actively recruiting Nonalcoholic Steatohepatitis studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Nonalcoholic Steatohepatitis clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Nonalcoholic Steatohepatitis clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.